10x Genomics downgraded to Neutral from Buy at Citi

FierceBiotechADA: Pfizer pads case for berobenatide in obesity, adding validation to Metsera buy

Endpoints News#ADA26: Pfizer monthly shot shows effect on obesity, diabetes

Endpoints News#ADA26: Roche to start Phase 2 petrelintide, enicepatide combo trial this year

Endpoints NewsLawmakers propose China restrictions; #ASCO26 recap; and more

FierceBiotech‘It looks like this hypothesis will pan out’: Cullinan unveils data building case for autoimmune TCEs

Endpoints News#ADA26: Roche incretin shot works in mid-stage trial in type 1 diabetes

Clinical OMICsBlood-Based Risk Score Could Enable Earlier Lung Cancer Prevention

Clinical OMICsMicroglial State Shift May Determine Whether Alzheimer’s Disease Pathology Leads to Dementia

Endpoints NewsIn Washington, biotech's China hawks are winning the conversation

Clinical OMICsUniversal Coronavirus Vaccine Could Provide Protection Against Future Strains

Endpoints NewsIndustry seeks more clarity on commissioner's voucher program

BioWorldMoney raised by biopharma